The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet

P. J. Dickstein, O. Trindade, R. N. Goldberg, Eduardo Bancalari

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Cardiovascular responses to the calcium antagonists verapamil and nifedipine were evaluated in a piglet model of hypoxic pulmonary hypertension. All animals were mechanically ventilated and paralyzed. Cardiac output (CO), pulmonary artery (Ppa) and aortic blood pressure (AoP), pulmonary wedge pressure, right atrial pressure (Pra), and arterial blood gases were measured prior to and after pulmonary hypertension was induced by hypoxia and after administration of calcium-blocking agents. Results were compared to a control group of piglets subjected to a similar period of hypoxia. Verapamil infusion (0.15 mg/kg) resulted in a rapid decrease in Ppa, AoP and pulmonary vascular resistance (p < 0.05) which returned to baseline values by 15 min. Nifedipine (100 μg/kg) resulted in a decrease in Ppa at 1 min (p < 0.05) which remained significantly lower than controls throughout the study period. AoP declined precipitously during the same time period (p < 0.01). No significant change in Ppa was noted when nifedipine was administered at a dose of 10 μg/kg. For the most part, these drugs have a transient vasodilatory action on pulmonary as well as systemic circulation in this animal model; however, they might in higher doses be associated with significant systemic hypotension. For this reason, the use of these drugs in the treatment of hypoxic pulmonary hypertension in the neonate should be approached with caution.

Original languageEnglish
Pages (from-to)1262-1265
Number of pages4
JournalPediatric Research
Volume18
Issue number12
StatePublished - Dec 1 1984

Fingerprint

Nifedipine
Pulmonary Hypertension
Arterial Pressure
Verapamil
Calcium
Pulmonary Wedge Pressure
Atrial Pressure
Pharmaceutical Preparations
Cardiac Output
Vascular Resistance
Hypotension
Pulmonary Artery
Animal Models
Gases
Lung
Control Groups
Hypoxia

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Dickstein, P. J., Trindade, O., Goldberg, R. N., & Bancalari, E. (1984). The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. Pediatric Research, 18(12), 1262-1265.

The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. / Dickstein, P. J.; Trindade, O.; Goldberg, R. N.; Bancalari, Eduardo.

In: Pediatric Research, Vol. 18, No. 12, 01.12.1984, p. 1262-1265.

Research output: Contribution to journalArticle

Dickstein, PJ, Trindade, O, Goldberg, RN & Bancalari, E 1984, 'The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet', Pediatric Research, vol. 18, no. 12, pp. 1262-1265.
Dickstein, P. J. ; Trindade, O. ; Goldberg, R. N. ; Bancalari, Eduardo. / The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet. In: Pediatric Research. 1984 ; Vol. 18, No. 12. pp. 1262-1265.
@article{974e98a40aa743aa89c11f259d41f14d,
title = "The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet",
abstract = "Cardiovascular responses to the calcium antagonists verapamil and nifedipine were evaluated in a piglet model of hypoxic pulmonary hypertension. All animals were mechanically ventilated and paralyzed. Cardiac output (CO), pulmonary artery (Ppa) and aortic blood pressure (AoP), pulmonary wedge pressure, right atrial pressure (Pra), and arterial blood gases were measured prior to and after pulmonary hypertension was induced by hypoxia and after administration of calcium-blocking agents. Results were compared to a control group of piglets subjected to a similar period of hypoxia. Verapamil infusion (0.15 mg/kg) resulted in a rapid decrease in Ppa, AoP and pulmonary vascular resistance (p < 0.05) which returned to baseline values by 15 min. Nifedipine (100 μg/kg) resulted in a decrease in Ppa at 1 min (p < 0.05) which remained significantly lower than controls throughout the study period. AoP declined precipitously during the same time period (p < 0.01). No significant change in Ppa was noted when nifedipine was administered at a dose of 10 μg/kg. For the most part, these drugs have a transient vasodilatory action on pulmonary as well as systemic circulation in this animal model; however, they might in higher doses be associated with significant systemic hypotension. For this reason, the use of these drugs in the treatment of hypoxic pulmonary hypertension in the neonate should be approached with caution.",
author = "Dickstein, {P. J.} and O. Trindade and Goldberg, {R. N.} and Eduardo Bancalari",
year = "1984",
month = "12",
day = "1",
language = "English",
volume = "18",
pages = "1262--1265",
journal = "Pediatric Research",
issn = "0031-3998",
publisher = "Lippincott Williams and Wilkins",
number = "12",

}

TY - JOUR

T1 - The effect of calcium antagonists on hypoxic pulmonary hypertension in the piglet

AU - Dickstein, P. J.

AU - Trindade, O.

AU - Goldberg, R. N.

AU - Bancalari, Eduardo

PY - 1984/12/1

Y1 - 1984/12/1

N2 - Cardiovascular responses to the calcium antagonists verapamil and nifedipine were evaluated in a piglet model of hypoxic pulmonary hypertension. All animals were mechanically ventilated and paralyzed. Cardiac output (CO), pulmonary artery (Ppa) and aortic blood pressure (AoP), pulmonary wedge pressure, right atrial pressure (Pra), and arterial blood gases were measured prior to and after pulmonary hypertension was induced by hypoxia and after administration of calcium-blocking agents. Results were compared to a control group of piglets subjected to a similar period of hypoxia. Verapamil infusion (0.15 mg/kg) resulted in a rapid decrease in Ppa, AoP and pulmonary vascular resistance (p < 0.05) which returned to baseline values by 15 min. Nifedipine (100 μg/kg) resulted in a decrease in Ppa at 1 min (p < 0.05) which remained significantly lower than controls throughout the study period. AoP declined precipitously during the same time period (p < 0.01). No significant change in Ppa was noted when nifedipine was administered at a dose of 10 μg/kg. For the most part, these drugs have a transient vasodilatory action on pulmonary as well as systemic circulation in this animal model; however, they might in higher doses be associated with significant systemic hypotension. For this reason, the use of these drugs in the treatment of hypoxic pulmonary hypertension in the neonate should be approached with caution.

AB - Cardiovascular responses to the calcium antagonists verapamil and nifedipine were evaluated in a piglet model of hypoxic pulmonary hypertension. All animals were mechanically ventilated and paralyzed. Cardiac output (CO), pulmonary artery (Ppa) and aortic blood pressure (AoP), pulmonary wedge pressure, right atrial pressure (Pra), and arterial blood gases were measured prior to and after pulmonary hypertension was induced by hypoxia and after administration of calcium-blocking agents. Results were compared to a control group of piglets subjected to a similar period of hypoxia. Verapamil infusion (0.15 mg/kg) resulted in a rapid decrease in Ppa, AoP and pulmonary vascular resistance (p < 0.05) which returned to baseline values by 15 min. Nifedipine (100 μg/kg) resulted in a decrease in Ppa at 1 min (p < 0.05) which remained significantly lower than controls throughout the study period. AoP declined precipitously during the same time period (p < 0.01). No significant change in Ppa was noted when nifedipine was administered at a dose of 10 μg/kg. For the most part, these drugs have a transient vasodilatory action on pulmonary as well as systemic circulation in this animal model; however, they might in higher doses be associated with significant systemic hypotension. For this reason, the use of these drugs in the treatment of hypoxic pulmonary hypertension in the neonate should be approached with caution.

UR - http://www.scopus.com/inward/record.url?scp=0021715437&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021715437&partnerID=8YFLogxK

M3 - Article

C2 - 6522139

AN - SCOPUS:0021715437

VL - 18

SP - 1262

EP - 1265

JO - Pediatric Research

JF - Pediatric Research

SN - 0031-3998

IS - 12

ER -